Welcome back to the untold story, everybody. Today we're going to be talking about the important topic of women's health, and I wanted to first share with you my exclusive conversation this week with Health and Human Services Secretary

Robert F. Kennedy Jr. We spoke about the controversy surrounding hormone replacement therapy or

HRT. Big news on that this week, a huge reversal from the government in terms of their advice to women on

this. Here's our conversation.

And in 2002, a study called the Women's Health Initiative found that women taking

hormone replacement therapy may have an increased risk of breast cancer diagnoses.

The study was not statistically significant,

but it triggered a media frenzy and led to the FDA

applying unscientific black box warnings.

Bureaucrats at the FDA reacted out of fear,

not cold standard science.

The medical establishment doubled down in group think.

So the FDA says that black box warnings on hormone replacement therapies for menopausal

women were based on failed science, as you just heard there from the HHS secretary.

27% of postmenopausal women were taking HARTs in 1999,

but after this warning, the number plunged when women feared that they could have a higher risk of breast cancer.

Health and Human Services, Secretary Robert F. Kennedy, Jr., joins me now.

Secretary Kennedy, always good to have you with us.

Thank you for joining us today.

You know, I think this is a tricky. Thank you. It's a tricky subject. You know, for

women who have breast cancer history in their families, as I do, you've been told that

HRT could increase that risk to you.

...